Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Ackman Takes a Swing at Amazon — Should You?
Ackman Takes a Swing at Amazon — Should You?
[content-module:CompanyOverview|NASDAQ:AMZN]

Despite a mixed week of trading, shares of Amazon.com Inc (NASDAQ: AMZN) are set to close out May in a strong position, with shares sitting around the

Take-Two Rises 24% YTD: Here's Why You Should Stay Away From the Stock
Take-Two Rises 24% YTD: Here's Why You Should Stay Away From the Stock

Take-Two Interactive TTWO shares have surged 24% year to date (YTD), outperforming the Zacks Consumer Discretionary sector’s modest growth of 1%. TTWO’s competitors, Electronic Arts EA, Ubisoft U

PCE for April Shows Economic Resilience
PCE for April Shows Economic Resilience

Friday, May 30, 2025The Fed’s preferred measure of inflation, Personal Consumption Expenditures (PCE), are out for the month of April. Results were positive across the board — eyebrow-raisingly so

Should You Buy, Sell or Hold CrowdStrike Stock Before Q1 Earnings?
Should You Buy, Sell or Hold CrowdStrike Stock Before Q1 Earnings?

CrowdStrike CRWD is scheduled to report its first-quarter fiscal 2026 results on June 3, 2025.

CrowdStrike anticipates revenues between $1.1006 billion and $1.1064 billion for first-quarter fiscal

DELL Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
DELL Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall

Dell Technologies DELL reported non-GAAP earnings of $1.55 per share in first-quarter fiscal 2026, missing the Zacks Consensus Estimate by 9.88%. The bottom line increased 17% year over

Li Auto Q1 Earnings Decline Y/Y, Revenues Climb on Higher Delivery
Li Auto Q1 Earnings Decline Y/Y, Revenues Climb on Higher Delivery

Li Auto LI reported first-quarter 2025 earnings per share (EPS) of 13 cents, down from the prior-year quarter’s EPS of 17 cents. Revenues of $3.57 billion, however, increased from $3.55 million in

Can HubSpot Regain its Mojo After Alphabet's Buyout Snub?
Can HubSpot Regain its Mojo After Alphabet's Buyout Snub?

Shares of HubSpot Inc. HUBS have declined more than 20% in the past six months, following Alphabet Inc.’s GOOGL decision to shelve its buyout plans. From Alphabet's perspective, acquiring HubSpot

ATI Inks Agreement With Airbus to Supply Titanium Products
ATI Inks Agreement With Airbus to Supply Titanium Products

ATI Inc. ATI recently announced the signing of a multi-year agreement with Airbus, positioning itself as the top supplier of titanium plate, sheet and billet to the latter. The guaranteed share

NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study
NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study

Shares of Intellia Therapeutics NTLA were down 22.9% yesterday after it announced an update from the ongoing phase III study, evaluating the investigational in vivo genome-editing candidate

Regeneron, SNY Report Mixed Results From Late-Stage COPD Studies
Regeneron, SNY Report Mixed Results From Late-Stage COPD Studies

Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced mixed results from two late-stage studies, AERIFY-1 and AERIFY-2, on itepekimab for the treatment of chronic obstructive

Buy These 5 Low-Leverage Stocks Amid Volatile Market Sentiment
Buy These 5 Low-Leverage Stocks Amid Volatile Market Sentiment

The U.S. stock market showed mixed signals on May 29, with investors reacting to a combination of events. While NVIDIA’s strong quarterly results and a favorable ruling from the U.S. International

BD Stock Might See Short-term Decline After Warning on Tamponade Tubes
BD Stock Might See Short-term Decline After Warning on Tamponade Tubes

Becton, Dickinson and Company BDX, popularly known as BD, along with its subsidiary C.R. Bard Urology and Critical Care, recently issued an urgent update regarding the use of its esophagogastric

US Financial Firms Mull Over Crypto Expansion, Seek Regulatory Clarity
US Financial Firms Mull Over Crypto Expansion, Seek Regulatory Clarity

As the Donald Trump administration began its second term in January, it opened the doors for many U.S. financial firms to venture into crypto asset-related activities, given the favorable stance of

Here's Why Investors Should Give Landstar Stock a Miss Now
Here's Why Investors Should Give Landstar Stock a Miss Now

Landstar System, Inc. (LSTR) is currently mired in multiple headwinds, which, we believe, have made it an unimpressive investment option.

Let’s delve deeper.

LSTR: Key Risks to Watch

Southward

Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds
Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2025. Foreign exchange remains a major headwind for Abbott. The stock currently carries a Zacks Rank #3

IonQ vs. Microsoft: Which Quantum Cloud Stock Is the Better Buy Today?
IonQ vs. Microsoft: Which Quantum Cloud Stock Is the Better Buy Today?

Both IonQ, Inc. IONQ and Microsoft Corporation MSFT are making waves in the emerging field of quantum computing, each from very different positions. IonQ is a pure-play quantum computing pioneer

5 Sector ETFs That Beat the Market in May
5 Sector ETFs That Beat the Market in May

Wall Street staged a solid comeback in May from early April lows, which were triggered by the "Liberation Day" tariffs. The S&P 500 experienced the fastest recovery since 1982, according to Bespoke

Best Momentum Stock to Buy for May 30th
Best Momentum Stock to Buy for May 30th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 30th:

Marex Group PLC MRX: This company which provide diversified global financial

Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates
Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates

This week, Eli Lilly LLY announced plans to acquire SiteOne Therapeutics to expand its pain pipeline. Moderna MRNA announced that the U.S. Department of Health and Human Services (“HHS”) has

Lockheed Martin Wins $509M Contract for GPS III Satellite Project
Lockheed Martin Wins $509M Contract for GPS III Satellite Project

Lockheed Martin Corporation LMT recently won a contract worth nearly $509.8 million from the U.S. Air Force to develop Global Positioning System (GPS) III Follow-On Space Vehicles 21 and 22. The

3 Auto Equipment Stocks Holding Strong Amid Soft Industry Outlook
3 Auto Equipment Stocks Holding Strong Amid Soft Industry Outlook
The outlook for the Zacks Automotive - Original Equipment industry remains challenged, weighed down by macroeconomic headwinds and tariff-related demand volatility. The pull-forward in vehicle sales
Wall Street Analysts Predict a 25.17% Upside in Nexxen International Ltd. Sponsored ADR (NEXN): Here's  What You Should Know
Wall Street Analysts Predict a 25.17% Upside in Nexxen International Ltd. Sponsored ADR (NEXN): Here's What You Should Know

Shares of Nexxen International Ltd. Sponsored ADR (NEXN) have gained 16.4% over the past four weeks to close the last trading session at $11.72, but there could still be a solid upside left in the

Wall Street Analysts Think Pagaya Technologies Ltd. (PGY) Could Surge 28.6%: Read This Before Placing a Bet
Wall Street Analysts Think Pagaya Technologies Ltd. (PGY) Could Surge 28.6%: Read This Before Placing a Bet

Pagaya Technologies Ltd. (PGY) closed the last trading session at $17.13, gaining 50.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Does Pan American Silver (PAAS) Have the Potential to Rally 29.05% as Wall Street Analysts Expect?
Does Pan American Silver (PAAS) Have the Potential to Rally 29.05% as Wall Street Analysts Expect?

Pan American Silver (PAAS) closed the last trading session at $24.20, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Think Janus International Group (JBI) Could Surge 32.12%: Read This Before Placing a Bet
Wall Street Analysts Think Janus International Group (JBI) Could Surge 32.12%: Read This Before Placing a Bet

Shares of Janus International Group, Inc. (JBI) have gained 18.5% over the past four weeks to close the last trading session at $8.25, but there could still be a solid upside left in the stock if